Company page

Endonovo Therapeutics, Inc.

Endonovo Therapeutics, Inc. is a public company traded under the ticker ENDV in the American market, with a market capitalization of approximately $180,756. The company focuses on developing innovative therapeutics and technologies aimed at improving patient outcomes. Endonovo is committed to advancing its product pipeline and enhancing its position in the healthcare industry.